EUVIMEDEUVIMED entdecken
Crossref

Effect of Recombinant Tissue-Type Plasminogen Activator on Peripheral Blood Mononuclear Cells of Patients With Alteplase-Associated Angioedema

Francesco Palestra, Maria Bova, Giovanna Servillo, Massimiliano Chetta, Renato Ciardi, Paolo Candelaresi, Marina Tarsitano, Chiara Suffritti, Roberta Gualtierotti, Stefania Miniello, Anne L Ferrara, Gilda Varricchi und 3 weitere

Journal of Investigational Allergology and Clinical Immunology · 04.03.2026 · 37 (1)

DOI: 10.18176/jiaci.1146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigational Allergology and Clinical Immunology, online erschienen am 04.03.2026. Verfasst von Francesco Palestra und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recombinant tissue-type plasminogen activator (R-tPA) is a thrombolytic agent used to treat acute ischemic stroke (IS). A rare but serious adverse effect of R-tPA is angioedema, which is characterized by plasma extravasation and increased release of vasoactive factors such as bradykinin, vascular endothelial growth factor A (VEGF-A), CXCL8, angiopoietin-1 (ANGPT-1), and ANGPT-2.

Objective

To investigate whether R-tPA modulates immune cell activity differently in IS patients with and without angioedema, focusing on the release of vasoactive mediators from human peripheral blood mononuclear cells (PBMCs).

Methods

PBMCs were isolated from 7 healthy controls (HCs), 7 IS patients without angioedema, and 7 IS patients who developed angioedema during R-tPA treatment (ISAE). The production and/or release of CXCL8, VEGF-A, ANGPT-1, and ANGPT-2 following ex vivo stimulation with R-tPA was measured. Plasma levels of these mediators were also assessed in ISAE patients during both angioedema attacks and remission.

Results

R-tPA inhibited the spontaneous release of VEGF-A, ANGPT-1, and ANGPT-2 from the PBMCs of HCs and IS patients. In contrast, a significant increase in the release of these mediators after stimulation with R-tPA was observed in PBMCs from ISAE patients. Plasma concentrations of all 4 mediators were higher during angioedema attacks than in remission, with a statistically significant elevation recorded for ANGPT-2.

Conclusions

These preliminary data suggest that R-tPA–related angioedema may result from abnormal immune cell activation, leading to increased release of vasoactive mediators. This immune dysregulation may contribute to the pathophysiology of angioedema in susceptible IS patients treated with R-tPA.

Schlagwörter

Stichwörter der Autor:innen

AngioedemaAngiopoietinsBradykininIschemic strokeVascular endothelial growth factor

Autor:innen und Institutionen

  • Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
  • WAO Center of Excellence, Naples, Italy.
  • Division of Internal Medicine 2, Department of Medicine and Medical Specialties, AORN A. Cardarelli Hospital, Naples, Italy.
  • UOC of Neurology and Stroke Unit, AORN Cardarelli, Naples, Italy.
  • UOC of Medical and Laboratory Genetics, AORN Cardarelli, Naples, Italy.
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.

Zitieren

APA

Palestra, F., Bova, M., Servillo, G., Chetta, M., Ciardi, R., Candelaresi, P., Tarsitano, M., Suffritti, C., Gualtierotti, R., Miniello, S., Ferrara, A. L., Varricchi, G., Cavallaro, R., Andreone, V., & Loffredo, S. (2026). Effect of Recombinant Tissue-Type Plasminogen Activator on Peripheral Blood Mononuclear Cells of Patients With Alteplase-Associated Angioedema. Journal of Investigational Allergology and Clinical Immunology, 37(1). https://doi.org/10.18176/jiaci.1146

Vancouver

Palestra F, Bova M, Servillo G, Chetta M, Ciardi R, Candelaresi P, et al. Effect of Recombinant Tissue-Type Plasminogen Activator on Peripheral Blood Mononuclear Cells of Patients With Alteplase-Associated Angioedema. Journal of Investigational Allergology and Clinical Immunology. 2026;37(1). doi:10.18176/jiaci.1146

BibTeX
@article{Palestra2026,
  author = {Palestra, Francesco and Bova, Maria and Servillo, Giovanna and Chetta, Massimiliano and Ciardi, Renato and Candelaresi, Paolo and Tarsitano, Marina and Suffritti, Chiara and Gualtierotti, Roberta and Miniello, Stefania and Ferrara, Anne L and Varricchi, Gilda and Cavallaro, Raimondo and Andreone, Vincenzo and Loffredo, Stefania},
  title = {Effect of Recombinant Tissue-Type Plasminogen Activator on Peripheral Blood Mononuclear Cells of Patients With Alteplase-Associated Angioedema},
  journal = {Journal of Investigational Allergology and Clinical Immunology},
  year = {2026},
  volume = {37},
  number = {1},
  doi = {10.18176/jiaci.1146}
}
Kostenlos starten →